Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation

被引:44
|
作者
Liang, Zhaoguang [1 ]
Dong, Zengxiang [1 ,2 ]
Guo, Meihua [2 ]
Shen, Zhaoqian [1 ]
Yin, Dechun [1 ]
Hu, Shuang [2 ]
Hai, Xin [2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Pharm, Harbin 150001, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
atrial fibrillation (AF); ischemic stroke (IS); risk factors; trimethylamine N-oxide (TMAO); INTESTINAL MICROBIOTA; GUT MICROBIOTA; PROGNOSTIC VALUE; MONOOXYGENASE; PHOSPHATIDYLCHOLINE; METABOLITE; MORTALITY; CARNITINE; PATHWAY; CHOLINE;
D O I
10.1002/jbt.22246
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Trimethylamine N-oxide (TMAO) is an independent risk factor of cardiovascular disease. Our objective was to explore the relation between TMAO and ischemic stroke (IS) in patients with atrial fibrillation (AF). A total of 68 patients with AF with IS and 111 ones without IS were enrolled. The plasma levels of TMAO remarkably increased in IS-AF patients (8.25 +/- 1.58 mu M) compared with patients with AF (2.22 +/- 0.09 mu M, P < 0.01). The receiver operating characteristic analysis revealed that the best cutoff value of TMAO to predict IS in patients with AF was 3.53 mu M with 75.0% sensitivity and 92.8% specificity (area under the curve: 0.917, 95% confidence intervals: 0.877-0.957). Univariate and multivariate logistic regression analysis showed that TMAO was an independent predictor in IS. The level of TMAO was correlated with the CHA2DS2-VASc score. In conclusion, TMAO was an independent predictor of IS, which could potentially refine stroke stratification in patients with AF.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Sleep apnea and risk of ischemic stroke in patients with atrial fibrillation
    Koch, H.
    Carlson, N.
    Jakobsen, C.
    Schou, M.
    Nielsen, O. Wendelboe
    Tonnesen, P.
    Torp-Pedersen, C.
    Gislason, G.
    Lamberts, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 302 - 303
  • [22] Unraveling the Effects of Trimethylamine N-Oxide on Stroke: "The lower, the better?"
    Yamashita, Tomoya
    Yoshida, Naofumi
    Emoto, Takuo
    Hirata, Ken-ichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (04) : 314 - 316
  • [23] Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality
    Kanitsoraphan C.
    Rattanawong P.
    Charoensri S.
    Senthong V.
    Current Nutrition Reports, 2018, 7 (4) : 207 - 213
  • [24] Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients
    Nie, Jing
    Xie, Liling
    Zhao, Bo-xin
    Li, Youbao
    Qiu, Bingbing
    Zhu, Fengxin
    Li, Guo-feng
    He, Mingli
    Wang, Yu
    Wang, Binyan
    Liu, Side
    Zhang, Hao
    Guo, Huiyuan
    Cai, Yefeng
    Huo, Yong
    Hou, Fan Fan
    Xu, Xiping
    Qin, Xianhui
    STROKE, 2018, 49 (09) : 2021 - 2028
  • [25] Risk of ischemic stroke recurrence in patients with atrial fibrillation diagnosed after stroke
    Sposato, Luciano A.
    Cerasuolo, Joshua O.
    Cipriano, Lauren E.
    Fang, Jiming
    Fridman, Sebastian
    Paquet, Maryse
    Saposnik, Gustavo
    NEUROLOGY, 2018, 90
  • [26] Atrial Fibrillation: a Marker or Risk Factor for Stroke
    Tatarsky, B. A.
    Napalkov, D. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (01) : 83 - 88
  • [27] ATRIAL-FIBRILLATION - RISK MARKER FOR STROKE
    CHESEBRO, JH
    FUSTER, V
    HALPERIN, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (22): : 1557 - 1558
  • [28] Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowinski, Artur
    Ufnal, Marcin
    NUTRITION, 2018, 46 : 7 - 12
  • [29] Left atrial volume index in ischemic stroke patients: A promising marker for underlying atrial fibrillation?
    Aaqib, M.
    Bates, T.
    Ghia, D.
    White, J.
    Sankhesara, D.
    Erickson, M.
    Hird, K.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (1_SUPPL) : 3 - 3
  • [30] Plasma trimethylamine-N-oxide is associated with atrial fibrillation
    Svingen, G. F. T.
    Ueland, P. M.
    Seifert, R.
    Loland, K. H.
    Pedersen, R. P.
    Schuster, P. M.
    Karlsson, T.
    Tell, G. S.
    Schartum-Hansen, H.
    Svenningsson, M. M.
    Strand, E.
    Nilsen, D. W.
    Nordrehaug, J. E.
    Nygaard, O. K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 561 - 561